Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
43m
on MSN
EU regulator backs use of Novo's Wegovy for obesity-related heart condition
The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...
STAT
44m
Novo’s new obesity drug shows modest results, raises concerns of psychiatric side effects
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...
55m
on MSN
Novo’s Wegovy Backed by EU Regulator For Obesity-Related Heart Conditions. FDA Could Be Next.
Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Secret Service probing post
Body found in SUV
FCC chair denies Trump call
Boy kills bear, saves father
Cancels appearance w/ Duda
Families lose appeal
Ban called for in TX schools
To get a second moon
NYC subway joyride arrest
Man charged for threats
Wonder announces tour
Hold campaign event in MI
Recalling 449K+ vehicles
MS sheriff's office probe
$3B for battery projects
Collapse hazard recall
Vows to remain in race
PGA welcomes LIV players
To visit US next week
FTC on privacy controls
Retires after 17 seasons
Brazil threatens daily fines
160M euros to Ukraine
Gun case sentencing delay
Hails economic progress
EU warns Apple
COVID, Wuhan market link
Overdose deaths drop in US
To receive Holbrooke award
Makes MLB history
Related topics
European Union
Novo Nordisk
Ozempic
Heart failure
Amycretin
Feedback